S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
NYSE:MET

MetLife - MET Price Target & Analyst Ratings

$74.59
-0.69 (-0.92%)
(As of 12/7/2022 12:00 AM ET)
Add
Compare
Today's Range
$74.41
$75.79
50-Day Range
$60.78
$76.95
52-Week Range
$57.41
$77.36
Volume
3.45 million shs
Average Volume
4.42 million shs
Market Capitalization
$58.52 billion
P/E Ratio
28.04
Dividend Yield
2.66%
Price Target
$78.18

MetLife Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 12 Analyst Ratings

Consensus Analyst Price Target

$78.18
4.82% Upside
High Prediction$87.00
Average Prediction$78.18
Low Prediction$74.00
TypeCurrent
12/8/21 to 12/8/22
1 Month Ago
11/8/21 to 11/8/22
3 Months Ago
9/9/21 to 9/9/22
1 Year Ago
12/8/20 to 12/8/21
Consensus Rating
Moderate Buy
Moderate Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
11 Buy rating(s)
12 Buy rating(s)
11 Buy rating(s)
9 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$78.18$77.33$76.92$68.60
Predicted Upside4.82% Upside17.41% Upside18.91% Upside12.94% Upside
Get MetLife Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.


MET Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MET Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

MetLife Stock vs. The Competition

TypeMetLifeFinance CompaniesS&P 500
Consensus Rating Score
2.92
2.45
2.48
Consensus RatingModerate BuyHoldHold
Predicted Upside4.80% Upside63.56% Upside15.62% Upside
News Sentiment RatingNeutral News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
899
74.17%
Underperform Votes
313
25.83%
Avg. Outperform Votes
149
62.08%
Avg. Underperform Votes
91
37.92%
Avg. Outperform Votes
851
68.08%
Avg. Underperform Votes
399
31.92%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/17/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$85.00 ➝ $87.00+17.27%
11/16/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$77.00 ➝ $84.00+13.09%
11/3/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$74.00 ➝ $77.00+5.05%
10/12/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$75.00 ➝ $74.00+16.96%
9/21/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform
8/22/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$68.00 ➝ $77.00+14.26%
8/9/2022Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$81.00+27.08%
7/19/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Set Target$75.00+23.36%
6/22/2022Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Zaremski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$70.00 ➝ $74.00+19.84%
4/6/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$77.00 ➝ $80.00+14.27%
1/25/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$74.00+13.10%
1/12/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$74.00 ➝ $77.00+12.99%
12/2/2021The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$77.00+29.78%
5/7/2021Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$66.00 ➝ $74.00+10.78%
2/17/2021Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetPositive ➝ Buy$53.00 ➝ $63.00+12.48%
12/8/2020Smith Barney Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$39.00 ➝ $55.00+15.59%
6/1/2020Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy
(Data available from 12/8/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












MET Price Target - Frequently Asked Questions

What is MetLife's consensus rating and price target?

According to the issued ratings of 12 analysts in the last year, the consensus rating for MetLife stock is Moderate Buy based on the current 1 hold rating and 11 buy ratings for MET. The average twelve-month price prediction for MetLife is $78.18 with a high price target of $87.00 and a low price target of $74.00. Learn more on MET's analyst rating history.

Do Wall Street analysts like MetLife more than its competitors?

Analysts like MetLife more than other Finance companies. The consensus rating for MetLife is Moderate Buy while the average consensus rating for finance companies is Hold. Learn more on how MET compares to other companies.

Do MarketBeat users like MetLife more than its competitors?

MarketBeat users like MetLife more than other Finance companies. 74.17% of MarketBeat users gave MetLife an outperform vote while finance companies recieve an average of 62.08% outperform votes by MarketBeat users.

Does MetLife's stock price have much upside?

According to analysts, MetLife's stock has a predicted upside of 16.70% based on their 12-month price targets.

What analysts cover MetLife?

MetLife has been rated by Citigroup, JPMorgan Chase & Co., Morgan Stanley, Raymond James, and Wells Fargo & Company in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:MET) was last updated on 12/8/2022 by MarketBeat.com Staff